Carmignac Gestion purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 12,000 shares of the company's stock, valued at approximately $716,000.
Several other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in Astera Labs by 0.9% in the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock worth $554,780,000 after buying an additional 85,846 shares during the last quarter. Lord Abbett & CO. LLC grew its position in Astera Labs by 318.9% in the fourth quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company's stock worth $240,873,000 after buying an additional 1,384,498 shares during the last quarter. Driehaus Capital Management LLC grew its position in Astera Labs by 16,640.4% in the fourth quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock worth $175,408,000 after buying an additional 1,316,419 shares during the last quarter. Bank of Nova Scotia grew its position in Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock worth $57,546,000 after buying an additional 939,300 shares during the last quarter. Finally, Polar Capital Holdings Plc acquired a new position in Astera Labs in the fourth quarter worth approximately $126,812,000. Institutional investors and hedge funds own 60.47% of the company's stock.
Analyst Ratings Changes
A number of equities analysts recently commented on ALAB shares. Needham & Company LLC raised their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Susquehanna raised their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a research note on Thursday, August 7th. Barclays reaffirmed an "overweight" rating and issued a $155.00 price objective (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Evercore ISI raised their price objective on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Finally, Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and a consensus target price of $129.13.
View Our Latest Stock Report on ALAB
Astera Labs Stock Down 3.8%
Shares of NASDAQ:ALAB traded down $6.8340 during trading on Monday, reaching $172.2560. 1,832,011 shares of the company traded hands, compared to its average volume of 4,954,625. The firm has a market cap of $28.63 billion, a P/E ratio of 309.23, a price-to-earnings-growth ratio of 4.54 and a beta of 1.39. The firm has a fifty day simple moving average of $123.97 and a 200 day simple moving average of $92.74. Astera Labs, Inc. has a 1-year low of $36.85 and a 1-year high of $199.47.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs's revenue for the quarter was up 149.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.
Insider Activity at Astera Labs
In other news, General Counsel Philip Mazzara sold 7,237 shares of Astera Labs stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $1,328,061.87. Following the transaction, the general counsel directly owned 171,573 shares in the company, valued at approximately $31,485,361.23. The trade was a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the firm's stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the sale, the director directly owned 99,154 shares in the company, valued at $17,195,286.68. This trade represents a 20.14% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,385,416 shares of company stock valued at $298,063,981. 12.50% of the stock is owned by corporate insiders.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report